New York-Esophageal-1 (NY-ESO-1), is a CTA whose expression occurs in several cancers including ∼30% lung cancers [8, 9], as well as in ovarian, head and neck cancers, melanoma, sarcomas and neuroblastoma [10]. This evidence concerns the gene CTAG1B and lung cancer.